Multi-parametric mri-directed focal salvage permanent interstitial brachytherapy for locally recurrent adenocarcinoma of the prostate: A novel approach

Journal of Cancer

Volumn 4, Issue 2, 2013, Pages 146-151

  Wallace, T ^a,c   Avital, I ^a   Stojadinovic, A ^b   Brucher, B ^c   Cote E ^d   Yu, J ^e  

^a Bon Secours Health System   (United States)

^b WALTER REED ARMY MEDICAL CENTER   (United States)

^c Theodor Billroth Academy   (Germany)

^d Virginia Urology   (United States)

^e VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Brachytherapy multi parametric MRI; Prostate cancer; Salvage therapy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

AGED; ARTICLE; BLADDER EMPTYING; BRACHYTHERAPY; BRACHYTHERAPY IMPLANT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CASE REPORT; DIFFUSION WEIGHTED IMAGING; DIGITAL RECTAL EXAMINATION; DYSURIA; EXTERNAL BEAM RADIOTHERAPY; GLEASON SCORE; HEMATURIA; HUMAN; HUMAN TISSUE; IMAGE GUIDED RADIOTHERAPY; LYMPHADENOPATHY; MALE; MICTURITION; MORBIDITY; NOCTURIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PROCTITIS; PROSTATE ADENOCARCINOMA; PROSTATE BIOPSY; PROSTATE VOLUME; RADIATION DOSE; SALVAGE THERAPY; SEMINAL VESICLE; TRANSRECTAL ULTRASONOGRAPHY; URINARY URGENCY; URINE INCONTINENCE;

EID: 84882943389     PISSN: None     EISSN: 18379664     Source Type: Journal    
DOI: 10.7150/jca.5419     Document Type: Article

References (34)

1. Chade DC et al. Salvage radical prostatectomy for radiation-recurrent prostate cancer: a multi-institutional collaboration. Eur Urol. 2011 Aug; 60(2):205-10.
2. Ward JF et al. Salvage surgery for radiorecurrent prostate cancer: contemporary outcomes. J Urol. 2005 Apr; 173(4):1156-60.
3. Sanderson KM, et al. Salvage radical prostatectomy: quality of life outcomes and long-term oncological control of radiorecurrent prostate cancer. J Urol. 2006 Nov; 176(5):2025-31.
4. Chade DC, et al. Cancer control and functional outcomes of salvage radical prostatectomy for radiation-recurrent prostate cancer: a systematic review of the literature. Eur Urol. 2012 May; 61(5):961-71.
5. Pisters LL, et al. The efficacy and complications of salvage cryotherapy of the prostate. J Urol. 1997 Mar; 157(3):921-5.
6. Grado GL, et al. Salvage brachytherapy for localized prostate cancer after radiotherapy failure. Urology. 1999 Jan; 53(1):2-10.
7. Burri RJ, et al. Long-term outcome and toxicity of salvage brachytherapy for local failure after initial radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2010 Aug 1; 77(5):1338-44.
8. Nguyen PL, et al. Magnetic resonance image-guided salvage brachytherapy after radiation in select men who initially presented with favorable- risk prostate cancer. Cancer 2007 Oct; 110(7):1485-92.
9. Rouviere O, et al. Recurrent prostate cancer after external beam radiotherapy: value of contrast-enhanced dynamic MRI in localizing intraprostatic tumor-correlation with biopsy findings. Urology. 2004 May; 63(5):922-7.
10. Kim CK, et al. Prediction of locally recurrent prostate cancer after radiation therapy: incremental value of 3T diffusion-weighted MRI. J Magn Reson Imaging. 2009 Feb; 29(2):391-7.
11. Haider MA, et al. Dynamic contrast-enhanced magnetic resonance imaging for localization of recurrent prostate cancer after external beam radiotherapy. Int J Radiat Oncol Biol Phys. 2008 Feb 1; 70(2):425-30.
12. Moman MR, et al. Focal salvage guided by T2-weighted and dynamic contrast-enhanced magnetic resonance imaging for prostate cancer recurrences. Int J Radiat Oncol Biol Phys. 2010 Mar 1; 76(3):741-6.
13. Hsu CC, et al. Feasibility of MRimaging/MR spectroscopy-planned focal partial salvage permanent prostate implant (PPI) for localized recurrence after initial PPI for prostate cancer. Int J Radiat Oncol Biol Phys. 2012; [epub ahead of print].
14. Hanlon AL, et al. Failure pattern implications following external beam irradiation of prostate cancer: long-term follow up and indications of cure. Cancer J. 2000 Apr; 6 Suppl 2:S193-7.
15. Arakawa A, et al. High grade prostatic intraepithelial neoplasia in prostates removed following irradiation failure in the treatment of prostatic adenocarcinoma. Pathol Res Pract. 1995 Sep; 191(9):868-72.
16. Cheng L, et al. Prevelance and distribution of prostatic intraepithelial neoplasia in salvage radical prostatectomy specimens after radiation therapy. Am J Surg Pathol. 1999 Jul; 23(7):803-8.
17. Alicikus ZA, et al. Ten-year outcomes of high-dose, intensity modulated radiotherapy for localized prostate cancer. Cancer. 2011 Apr 1; 117(7):1429-37.
18. Sartor CI, et al. Rate of PSA rise predicts metastatic versus local recurrence after definitive radiotherapy. Int J Radiat Oncol Biol Phys. 1997 Jul 15; 38(5):941-7.
19. Isaacs JT. The biology of hormone refractory prostate cancer. Why does it develop. Urol Clin North Am. 1999 May; 26(2):263-73.
20. Saigal CS, et al. Androgen deprivation therapy increases cardiovascular morbidity in men with prostate cancer. Cancer. 2007 Oct 1; 110(7):1493-500.
21. Tsai HK, et al. Androgen deprivation therapy for localized prostate cancer and the risk of cardiovascular mortality. J Natl Cancer Inst. 2007 Oct 17; 99(20):1516-24.
22. Tan CH, et al. Diffusion weighted imaging in prostate cancer. Eur Radiol 2011; 21: 593-603.
23. Turkbey B, et al. Is apparent diffusion coefficient associated with clinical risk scores for prostate cancers that are visible on 3-T MR images?. Radiology 2011; 258: 488-495.
24. Alonzi R, et al. Dynamic contrast enhanced MRI in prostate cancer. Eur J Radiol 2007; 63: 335-50.
25. Villers A, et al. Dynamic contrast enhanced, pelvic phased array magnetic resonance imaging of localized prostate cancer for predicting tumor volume: correlation with radical prostatectomy findings. J Urol. 2006; 176:2432-37.
26. Verma S, et al. Prostate MRI and 3D MR spectroscopy: how we do it. AJR Am J Roentgenol 2010; 194: 1414-26.
27. Hosseinzadeh K and Schwarz SD. Endorectal diffusion-weighted imaging in prostate cancer to differentiate malignant and benign peripheral zone tissue. J Magn Reson Imaging. 2004 Oct; 20(4):654-61.
28. Preziosi P, et al. Enhancement patterns of prostate cancer in dynamic MRI. Eur Radiol. 2003 May; 13(5):925-30.
29. Rouviere O, et al. Characterization of time-enhancement curves of benign and malignant prostate tissue at dynamic MR imaging. Eur Radiol. 2003 May; 13(5):931-42.
30. Kurhanewicz J, et al. Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high spatial resolution. Radiology 1996;198:795-805
31. Coakley FV, et al. Endorectal MR imaging and MR spectroscopic imaging for locally recurrent prostate cancer after external beam radiation therapy: preliminary experience. Radiology. 2004 Nov; 233(2):441-8.
32. Scheidler J, et al. Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging - clinicopathologic study. Radiology 1999; 213:473-480.
33. Pickett B, et al. Time to metabolic atrophy after permanent prostate seed implantation based on magnetic resonance spectroscopic imaging. Int J Radiat Oncol Biol Phys. 2004 Jul 1; 59(3):665-73.
34. Arumainayagam N, et al. Accuracy of multiparametric magnetic resonance imaging in detecting recurrent prostate cancer after radiotherapy. BJU Int. 2010 Oct; 106(7):991-7.